Aytu Biopharma (AYTU) EBT Margin (2013 - 2026)
Aytu Biopharma's (AYTU) quarterly EBT Margin came in at 45.19% in Q1 2026, down 6588.0% year-on-year from 0.7% in Q1 2025, and up 35.26% on a QoQ basis from 69.79% in Q4 2025.
Aytu Biopharma (AYTU) EBT Margin (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 14 years of EBT Margin data on file, last reported at 45.19% in Q1 2026.
- On a quarterly basis, EBT Margin fell 6588.0% year-over-year to 45.19% in Q1 2026; TTM through Mar 2026 was 59.49%, a 6429.0% decrease from a year earlier, with the FY2025 full-year figure at 20.71%, down 478.0% from the prior year.
- EBT Margin for Q1 2026 stood at 45.19%, up from 69.79% in the prior quarter.
- Over the last five years, EBT Margin for AYTU reached as high as 20.69% in Q1 2025 and fell as low as 220.22% in Q1 2022.
- Historically, EBT Margin has averaged 35.78% across 5 years, with a median of 17.39% in 2024.
- Across the five-year window, EBT Margin soared 18855 bps in 2023 and sank 11108 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 25.47% in 2022, then soared by 129 bps to 7.46% in 2023, then slumped by 68 bps to 2.35% in 2024, then sank by 3064 bps to 69.79% in 2025, then jumped by 35 bps to 45.19% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 45.19% in Q1 2026, 69.79% in Q4 2025, and 14.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | -45.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.19% |
| Dec 31, 2025 | -69.79% |
| Sep 30, 2025 | 14.15% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 2.35% |
| Sep 30, 2024 | 9.04% |
| Jun 30, 2024 | -17.39% |
| Mar 31, 2024 | -12.60% |
| Dec 31, 2023 | 7.46% |
| Sep 30, 2023 | -41.94% |
| Jun 30, 2023 | -7.99% |
| Mar 31, 2023 | -31.67% |
| Dec 31, 2022 | -25.47% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -58.62% |
| Mar 31, 2022 | -220.22% |
| Dec 31, 2021 | -49.95% |
| Sep 30, 2021 | -127.68% |
| Jun 30, 2021 | -79.80% |